MVIR — Medivir AB Income Statement
0.000.00%
Last trade - 00:00- SEK1.02bn
- SEK903.74m
- SEK8.50m
Annual income statement for Medivir AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 25.5 | 4.41 | 7.63 | 3.48 | 8.5 |
| Cost of Revenue | |||||
| Gross Profit | 32.4 | — | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 87.7 | 91.8 | 99 | 131 | 101 |
| Operating Profit | -62.1 | -87.4 | -91.4 | -127 | -92.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -62.6 | -88.8 | -89.3 | -123 | -94.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -63.1 | -88.8 | -89.3 | -123 | -94.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -63.1 | -88.8 | -89.3 | -123 | -94.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -63.1 | -88.8 | -89.3 | -123 | -94.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.986 | -1.31 | -1.48 | -1.08 | -0.662 |
| Dividends per Share |